NOT-TR-20-011
| Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
| NCATS
| CTSA (CTRI) award specific. PA-20-272 for UL1, U01, and R21 awards; PAR-19-099 for U01 specific awards; PAR-19-100 for R21 specific awards; PAR-19-337 for UL1 specific awards.
- Update: NOT-TR-20-018 expands the eligibility and activity codes to include U24 parent awards.
Due Date: varies per award mechanism and FOA. See NOSI.
|
NOT-AG-20-022
| Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
| NIA
| Administrative supplement work that is proposed through PA-20-272 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through PA-18-935. An FAQ page was created to assist those interested in applying to this NOSI. It can be found here. Due Date: applications will be accepted on a rolling basis from April 6, 2020 through May 1, 2021.
|
NOT-TR-20-016
| Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus
| NCATS
| Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent: PA-20-272. Due Date: applications will be accepted on a rolling basis from May 15, 2020 through January 25, 2022.
|
NOT-TR-20-017
| Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus
| NCATS
| Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent: PA-20-135.
Due Date: applications will be accepted on a rolling basis from May 15, 2020 to January 25, 2022.
|
NOT-MD-20-019
| Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities
| NIMHD
NIA
NIMH
| Administrative supplement work that is proposed through PA-20-272 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through PA-18-935. Due Date: applications will be accepted on a rolling basis from May 01, 2020 through May 01, 2021.
- NOT-MD-20-024: Notice of Information for Date of Submission to NOT-MD-20-019 and NIMHD Consideration for FY Award informs that all applications received by 5:00 PM on July 15, 2020 will be considered for funding in FY2020. Applications to NIMHD which are received after 5:00 PM (local time of the applicant institution) on July 15, 2020 may be held for consideration in Fiscal Year 2021 and not be eligible for funding before October 2020
|
NOT-ES-20-020
| Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
| NIEHS
| This replaced NOT-ES-20-015. Administrative supplement work that is proposed through
PA-18-591 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through
PA-18-935. If you are applying for a new R21 grant that does not build off of an existing NIEHS grant, apply to RFA-ES-19-011. Due Date: application Due Dates for all programs: May 1, 2020; June 1, 2020; July 1, 2020; August 3, 2020; September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; February 1, 2021; March 1, 2021; April 1, 2021; May 3, 2021.
|
NOT-DC-20-008
| Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders
| NIDCD
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice.
- PA-18-334 - NIDCD Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
- PA-20-185- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-184 – NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PA-20-196 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
Due Date: This notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through September 8, 2022
|
NOT-OD-20-129
|
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project
| OD
NHLBI
NHGRI
NIA
NIAID
NIAMS
NICHD
NIDCD
NIDCR
NIDDK
NIEHS
NINDS NIMHD
NCCIH
NCATS
ORIP
NCI |
Administrative supplement work that is proposed through PA-20-272 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through PA-18-935.Due Date: July 13, 2020, November 12, 2020, March 12, 2021, and July 12, 2021
|
NOT-AI-20-059
| Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
| NIAID
|
Applications in response to this NOSI must be submitted using the Emergency Competitive Revision to Existing NIH Awards: PA-20-135 (or its subsequent reissued equivalents). Due Date: applications will be accepted on a rolling basis 07/02/2020 to 07/02/2021.
|
NOT-AI-20-065
| Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2
| NIAID
|
Applications in response to this NOSI must be submitted using PAR-18-633 NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) (or its subsequent reissued equivalents). Due Date: September 14, 2020; October 14, 2020; November 14, 2020; December 14, 2020; January 14, 2021; February 14, 2021; March 14, 2021; April 14, 2021; May 14, 2021; June 14, 2021; July 14, 2021; ; August 14, 2021; and September 14, 2021. |
NOT-MD-20-025
|
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities
| NIMHD
NCI
NIDA
NLM
NIMH
NIAMS
The following NIH Offices may co-fund applications assigned to those I/Cs:
ODP
OBSSR
| Submit applications for this initiative using the following funding opportunity announcement (FOA) or any reissue of thid announcement through the expiration date of this notice:
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Due Date: this notice applies to due dates on or after October 5, 2020 and subsequent receipt dates through May 8, 2023.
|
NOT-HL-20-814
| Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)
| NHLBI
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this notice:
- PA-20-183 Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-185 Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Due Date: Applications will be accepted dates on or after October 5, 2020 and subsequent receipt dates through July 5, 2024 of reissued FOAs.
|
NOT-AI-21-002
|
Emergency Awards: Notice of Special Interest (NOSI) on Pan-Coronavirus Vaccine Development Program Projects
| NIAID
| Applications in response to this NOSI must be submitted using the following funding opportunity: PAR-20-072; NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed). Due Date: Applications will be received on two receipt dates: January 11, 2021 and June 11, 2021.
|
NOT-TR-21-011
| Notice of Special Interest (NOSI): Availability of Emergency Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs
| NCATS
| CTSA (CTRI) award specific. Applications for this initiative must be submitted using the following opportunity announcements or the subsequent reissued equivalent: PA-20-272. Due Date: Applications will be accepted immediately and on a rolling basis through June 1, 2021.
|
NOT-MD-21-008
| Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
| NCI
NHLBI
NIAAA
NIAID
NIAMS
NIDA
NIDCR
NIMH
NINR
The following NIH Offices may co-fund applications assigned to those I/Cs:
OBSSR
ODP
ORWH
NIMHD
| Applications for this initiative must be submitted using the following opportunity announcements or the subsequent reissued equivalent:
- PA-20-183 - Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Due Date: The first available due date is Feburary 5, 2021. Applications can be submitted through January 7, 2022.
|
NOT-MH-21-120
|
Notice of Special Interest: Administrative Supplements for COVID-19 Impacted NIMH Research
| NIMH
| Applications for this initiative must be submitted using the following opportunity announcements or the subsequent reissued equivalent: PA-20-272. Due Date: Applications will be accepted for due dates on or after January 5, 2021 with rolling receipt through June 1, 2023. |
NOT-DA-20-084
| Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
| NIDA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this notice:
- PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
- PA-20-195 - NIH Exploratory/Developmental Research Grant (Parent R21Clinical Trial Not Allowed)
|
NOT-NS-21-037
| Notice of Special Interest: Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populations
| NINDS
| Applications for this initiative must be submitted using the following opportunity announcements or the subsequent reissued equivalent: PA-20-272. Due Date: May 5, 2021
|
NOT-GM-21-032
|
Notice of Special Interest (NOSI): Administrative Supplements to SEPA Awards to Develop Innovative Educational Resources to Address SARS-CoV-2 Vaccine Hesitancy
| NIGMS
|
Applications for this initiative must be submitted using the following opportunity announcements or the subsequent reissued equivalent: PA-20-272. Due Date: April 23, 2021
|
NOT-GM-21-021
| Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy
| NIGMS
SGMRO
| Applications for this initiative must be submitted using the following opportunity announcements or the subsequent reissued equivalent: PA-18-935. Due Date: 4/30/2021
|
NOT-TR-21-022
|
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
| NCATS
| CTSA (CTRI) award specific. Applications for this initiative must be submitted using the following opportunity announcements or the subsequent reissued equivalent PA-20-135. Due Date: Applications will be accepted immediately and on a rolling basis through August 16, 2024.
|
NOT-AR-21-012
|
Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases
| NIAMS
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PAR-21-055 - Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
- PAR-21-054 - Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
- PAR-21-053 - Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Due Date: Applications will be accepted for due dates on or after February 5, 2021 and subsequent receipt dates through November 18, 2021. |
NOT-DA-21-011
| Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
| NIDA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PA-20-183 - Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
- PA-20-195 - NIH Exploratory/Developmental Research Grant (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
- PA-20-196 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)
- PA-20-146 - NIDA Small Research Grant Program (R03 Clinical Trial Required)
Due Date: Applications will be accepted for due dates on or after June 5, 2021 and subsequent receipt dates through September 8, 2024.
|
NOT-AG-21-015
| Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19)
| NIA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - Parent R21 Exploratory/Developmental Grant, Clinical Trial Required
- PA-20-196 - Parent R21 Exploratory/Developmental Grant, Basic Experimental Studies with Humans Required
- PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
- PAR-19-374 - Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
- PAR-19-314 - NIA Program Project Applications (P01 Clinical Trial Optional)
- PAR-19-070 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
- PAR-19-071 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)
- PAR-20-070 - Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)
Due Date: Applications will be accepted for due dates on or after March 4, 2021 and subsequent receipt dates through May 7, 2023.
|
NOT-AG-21-016
| Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration
| NIA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - Parent R21 Exploratory/Developmental Grant, Clinical Trial Required
- PA-20-196 - Parent R21 Exploratory/Developmental Grant, Basic Experimental Studies with Humans Required
- PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
Due Date: Applications will be accepted for due dates on or after June 5, 2021 and subsequent receipt dates through May 7, 2023.
|
NOT-GM-21-019
| Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
| NIGMS
| Applications for this initiative must be submitted using the following opportunity announcements or the subsequent reissued equivalent:
PA-18-935. Due Date: Applications will be accepted on a rolling basis from March 15, 2021 to December 15, 2021.
|
NOT-DA-21-019
| Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders
| NIDA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - Parent R21 Exploratory/Developmental Grant, Clinical Trial Required
- PA-20-196 - Parent R21 Exploratory/Developmental Grant, Basic Experimental Studies with Humans Required
- PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
Due Date: Applications will be accepted for due dates on or after May 7, 2021 and subsequent receipt dates through September 7, 2024.
|
NOT-DA-21-017
| Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19
| NIDA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - Parent R21 Exploratory/Developmental Grant, Clinical Trial Required
- PA-20-196 - Parent R21 Exploratory/Developmental Grant, Basic Experimental Studies with Humans Required
Due Date: Applications will be accepted for due dates on or after May 5, 2021 and subsequent receipt dates through September 7, 2024.
|
NOT-AI-21-008
| Notice of Special Interest (NOSI): Complement in Basic Immunology (CIBI)
| NIAID
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
Due Date: Applications will be accepted for due dates on or after June 5, 2021 and subsequent receipt dates through January 7, 2023.
|
NOT-DA-21-018
| Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
| NIDA
| Submit applications for this initiative using one of the following funding opportunity announcements (FOAs), or any reissues of these announcements, through the expiration date of this NOSI:
- PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- PA-20-183 - NIH Research Project Grant (Parent R01 Clinical Trial Required)
- PA-20-184 - Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PA-20-195 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
- PA-20-194 - Parent R21 Exploratory/Developmental Grant, Clinical Trial Required
- PA-20-196 - Parent R21 Exploratory/Developmental Grant, Basic Experimental Studies with Humans Required
- PA-20-200 - NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
Due Date: Applications will be accepted for due dates on or after May 7, 2021 and subsequent receipt dates through September 7, 2024.
|
NOT-DA-21-041
| Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
| NIDA
| Applications for this initiative must be submitted using one of the following opportunity announcements or the subsequent reissued equivalent. PA-20-272 must be within the general scope of the research or training that is already supported. Applications that involve a change in scope (e.g., the addition of human subjects to a grant that has not been previously so coded and approved, the addition of vertebrate animals to a grant that has not been previously so coded and approved) must apply through PA-18-935. Due Date: Applications will be accepted on a rolling basis through March 31, 2022.
|